lysophosphatidic acid is a lipid of Glycerophospholipids (GP) class. Lysophosphatidic acid is associated with abnormalities such as Atherosclerosis, Alzheimer's Disease, Asthma, Diabetes Mellitus, Non-Insulin-Dependent and Septicemia. The involved functions are known as Inflammation, Chemotaxis, Binding (Molecular Function), Polymerization and Inflammatory Response. Lysophosphatidic acid often locates in Cytoskeleton, Microfilaments, actin cytoskeleton, Extracellular and Structure of germinal center of lymph node. The associated genes with lysophosphatidic acid are TNF gene, MAPK3 gene, RHOA gene, CDC42 gene and ADRBK1 gene. The related lipids are lysophosphatidic acid, Lipopolysaccharides, Lysophosphatidylcholines, Lysophospholipids and Phosphatidic Acid. The related experimental models are Knock-out, Transgenic Model, Rodent Model and Disease model.
PMID | Journal | Published Date | Author | Title |
---|---|---|---|---|
26037280 | Endocr. Relat. Cancer | 2015 | Benesch MG et al. | Autotaxin is an inflammatory mediator and therapeutic target in thyroid cancer. |
27544588 | Bioorg. Med. Chem. | 2016 | Ragle LE et al. | Discovery and synthetic optimization of a novel scaffold for hydrophobic tunnel-targeted autotaxin inhibition. |
25033840 | Mol. Cancer Res. | 2014 | Schneider G et al. | Bioactive lipids, LPC and LPA, are novel prometastatic factors and their tissue levels increase in response to radio/chemotherapy. |
28588064 | EMBO J. | 2017 | Aikawa S et al. | Autotaxin-lysophosphatidic acid-LPA3 signaling at the embryo-epithelial boundary controls decidualization pathways. |
27605627 | J. Pharmacol. Exp. Ther. | 2016 | Olianas MC et al. | LPA1 Mediates Antidepressant-Induced ERK1/2 Signaling and Protection from Oxidative Stress in Glial Cells. |
27641493 | Neuron | 2016 | Cheng J et al. | Precise Somatotopic Thalamocortical Axon Guidance Depends on LPA-Mediated PRG-2/Radixin Signaling. |
27562917 | Arterioscler. Thromb. Vasc. Biol. | 2016 | Gibbs-Bar L et al. | Autotaxin-Lysophosphatidic Acid Axis Acts Downstream of Apoprotein B Lipoproteins in Endothelial Cells. |
27474750 | J. Pharmacol. Exp. Ther. | 2016 | Hopkins MM et al. | Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells. |
27453502 | Dev. Cell | 2016 | Liu X et al. | PRG-1 Regulates Synaptic Plasticity via Intracellular PP2A/β1-Integrin Signaling. |
27401461 | Physiol Rep | 2016 | Sweat RS et al. | Lysophosphatidic acid does not cause blood/lymphatic vessel plasticity in the rat mesentery culture model. |
27305954 | Am. J. Clin. Nutr. | 2016 | Del Bas JM et al. | Impairment of lysophospholipid metabolism in obesity: altered plasma profile and desensitization to the modulatory properties of n-3 polyunsaturated fatty acids in a randomized controlled trial. |
27161483 | Cell Chem Biol | 2016 | Hövelmann F et al. | Optotaxis: Caged Lysophosphatidic Acid Enables Optical Control of a Chemotactic Gradient. |
27030671 | Mol. Biol. Cell | 2016 | Bartolini F et al. | An mDia1-INF2 formin activation cascade facilitated by IQGAP1 regulates stable microtubules in migrating cells. |
27013613 | Arterioscler. Thromb. Vasc. Biol. | 2016 | Ren B et al. | LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming. |
27006447 | FASEB J. | 2016 | Black KE et al. | Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis. |
26947063 | Cell Rep | 2016 | Qin H et al. | YAP Induces Human Naive Pluripotency. |
26671989 | EMBO Mol Med | 2016 | Vogt J et al. | Molecular cause and functional impact of altered synaptic lipid signaling due to a prg-1 gene SNP. |
26597701 | Biochim. Biophys. Acta | 2016 | Nan L et al. | Cross-talk between lysophosphatidic acid receptor 1 and tropomyosin receptor kinase A promotes lung epithelial cell migration. |
26476080 | Neoplasia | 2015 | Mukherjee A et al. | Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer Cells. |
26345369 | J. Cell. Sci. | 2015 | Yukiura H et al. | LPP3 localizes LPA6 signalling to non-contact sites in endothelial cells. |
26269646 | J. Neurosci. | 2015 | Wheeler NA et al. | The Autotaxin-Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression during Oligodendrocyte Differentiation. |
26180199 | J. Neurosci. | 2015 | Santos-Nogueira E et al. | Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury. |
26148725 | J. Endocrinol. | 2015 | Kaneko I et al. | FGF23 gene regulation by 1,25-dihydroxyvitamin D: opposing effects in adipocytes and osteocytes. |
26101324 | J. Immunol. | 2015 | McArthur S et al. | Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue Inflammation. |
26079546 | Exp. Mol. Pathol. | 2015 | Ayasolla KR et al. | Tubular cell phenotype in HIV-associated nephropathy: role of phospholipid lysophosphatidic acid. |
26041536 | J. Immunol. | 2015 | Causton B et al. | CARMA3 Is Critical for the Initiation of Allergic Airway Inflammation. |
25934709 | Mol. Cancer Ther. | 2015 | Xia Y et al. | Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo. |
25855080 | Am. J. Physiol., Cell Physiol. | 2015 | No YR et al. | Regulation of NHE3 by lysophosphatidic acid is mediated by phosphorylation of NHE3 by RSK2. |
25852197 | Development | 2015 | Sheng X et al. | Lysophosphatidic acid signalling in development. |
25695267 | Neuron | 2015 | Yung YC et al. | Lysophosphatidic Acid signaling in the nervous system. |
25683913 | Cell. Signal. | 2015 | Guo L et al. | Krüppel-like factor 5 incorporates into the β-catenin/TCF complex in response to LPA in colon cancer cells. |
25619933 | Chem. Biol. | 2015 | Patil R et al. | Combined mitigation of the gastrointestinal and hematopoietic acute radiation syndromes by an LPA2 receptor-specific nonlipid agonist. |
25578862 | Cell. Signal. | 2015 | Wallert MA et al. | RhoA Kinase (Rock) and p90 Ribosomal S6 Kinase (p90Rsk) phosphorylation of the sodium hydrogen exchanger (NHE1) is required for lysophosphatidic acid-induced transport, cytoskeletal organization and migration. |
25555354 | Prostaglandins Leukot. Essent. Fatty Acids | 2015 | Block RC et al. | The effects of aspirin on platelet function and lysophosphatidic acids depend on plasma concentrations of EPA and DHA. |
25464168 | Osteoarthr. Cartil. | 2015 | Wu L et al. | Lysophosphatidic acid mediates fibrosis in injured joints by regulating collagen type I biosynthesis. |
25451317 | Cancer Lett. | 2015 | Ward JD et al. | LPA-mediated migration of ovarian cancer cells involves translocalization of Gαi2 to invadopodia and association with Src and β-pix. |
25425621 | Arterioscler. Thromb. Vasc. Biol. | 2015 | Kurano M et al. | Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome. |
25344254 | J. Cell. Sci. | 2014 | Argenzio E et al. | CLIC4 regulates cell adhesion and β1 integrin trafficking. |
25277122 | Blood | 2014 | Leblanc R et al. | Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone. |
25190756 | Blood | 2014 | Hsieh WC et al. | Inability to resolve specific infection generates innate immunodeficiency syndrome in Xiap-/- mice. |
24750398 | HPB (Oxford) | 2014 | Simo KA et al. | Altered lysophosphatidic acid (LPA) receptor expression during hepatic regeneration in a mouse model of partial hepatectomy. |
24657741 | Free Radic. Biol. Med. | 2014 | Klomsiri C et al. | Endosomal H2O2 production leads to localized cysteine sulfenic acid formation on proteins during lysophosphatidic acid-mediated cell signaling. |
24530617 | J. Struct. Biol. | 2014 | García-González V et al. | Key structural arrangements at the C-terminus domain of CETP suggest a potential mechanism for lipid-transfer activity. |
24455753 | Cancer Immunol Res | 2013 | Oda SK et al. | Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression. |
24445011 | J. Formos. Med. Assoc. | 2014 | Wang CY et al. | Epigallocatechin-3-gallate inhibits lysophosphatidic acid-stimulated connective tissue growth factor via JNK and Smad3 suppression in human gingival fibroblasts. |